- Home
- MRNA vs TER Comparison
MRNA vs TER Comparison
Compare MRNA & TER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- TER
- Stock Information
- Founded
- MRNA 2010
- TER 1960
- Country
- MRNA United States
- TER United States
- Employees
- MRNA N/A
- TER N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- TER Electrical Products
- Sector
- MRNA Health Care
- TER Industrials
- Exchange
- MRNA Nasdaq
- TER Nasdaq
- Market Cap
- MRNA 16.0B
- TER 18.9B
- IPO Year
- MRNA 2018
- TER N/A
- Fundamental
- Price
- MRNA $35.53
- TER $115.91
- Analyst Decision
- MRNA Hold
- TER Buy
- Analyst Count
- MRNA 20
- TER 14
- Target Price
- MRNA $59.65
- TER $148.36
- AVG Volume (30 Days)
- MRNA 13.6M
- TER 2.8M
- Earning Date
- MRNA 02-14-2025
- TER 01-29-2025
- Dividend Yield
- MRNA N/A
- TER 0.41%
- EPS Growth
- MRNA N/A
- TER 21.61
- EPS
- MRNA N/A
- TER 3.32
- Revenue
- MRNA $3,236,000,000.00
- TER $2,819,880,000.00
- Revenue This Year
- MRNA N/A
- TER $16.60
- Revenue Next Year
- MRNA $21.39
- TER $19.28
- P/E Ratio
- MRNA N/A
- TER $34.91
- Revenue Growth
- MRNA N/A
- TER 5.36
- 52 Week Low
- MRNA $29.25
- TER $95.80
- 52 Week High
- MRNA $170.47
- TER $163.21
- Technical
- Relative Strength Index (RSI)
- MRNA 48.60
- TER 44.79
- Support Level
- MRNA $32.78
- TER $109.40
- Resistance Level
- MRNA $36.98
- TER $115.06
- Average True Range (ATR)
- MRNA 2.50
- TER 2.74
- MACD
- MRNA 0.30
- TER 0.60
- Stochastic Oscillator
- MRNA 66.81
- TER 57.94
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TER Teradyne Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.